Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of 111.26 billion. The enterprise value is 126.37 billion.
| Market Cap | 111.26B |
| Enterprise Value | 126.37B |
Important Dates
The next confirmed earnings date is Thursday, April 23, 2026.
| Earnings Date | Apr 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 1.21B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -2.43% |
| Shares Change (QoQ) | -0.44% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 49.61% |
| Float | 1.08B |
Valuation Ratios
The trailing PE ratio is 12.13 and the forward PE ratio is 9.50.
| PE Ratio | 12.13 |
| Forward PE | 9.50 |
| PS Ratio | 2.03 |
| PB Ratio | 1.32 |
| P/TBV Ratio | 7.55 |
| P/FCF Ratio | 10.54 |
| P/OCF Ratio | 8.81 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.52, with an EV/FCF ratio of 11.97.
| EV / Earnings | 13.78 |
| EV / Sales | 2.33 |
| EV / EBITDA | 8.52 |
| EV / EBIT | 11.44 |
| EV / FCF | 11.97 |
Financial Position
The company has a current ratio of 1.09, with a Debt / Equity ratio of 0.28.
| Current Ratio | 1.09 |
| Quick Ratio | 0.66 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 1.58 |
| Debt / FCF | 2.26 |
| Interest Coverage | 18.17 |
Financial Efficiency
Return on equity (ROE) is 6.66% and return on invested capital (ROIC) is 9.35%.
| Return on Equity (ROE) | 6.66% |
| Return on Assets (ROA) | 4.65% |
| Return on Invested Capital (ROIC) | 9.35% |
| Return on Capital Employed (ROCE) | 9.80% |
| Weighted Average Cost of Capital (WACC) | 5.55% |
| Revenue Per Employee | 732,842 |
| Profits Per Employee | 122,564 |
| Employee Count | 74,846 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 1.32 |
Taxes
In the past 12 months, Sanofi has paid 1.22 billion in taxes.
| Income Tax | 1.22B |
| Effective Tax Rate | 17.33% |
Stock Price Statistics
The stock price has decreased by -13.49% in the last 52 weeks. The beta is 0.37, so Sanofi's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | -13.49% |
| 50-Day Moving Average | 95.40 |
| 200-Day Moving Average | 99.83 |
| Relative Strength Index (RSI) | 55.08 |
| Average Volume (20 Days) | 81,540 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi had revenue of 54.85 billion and earned 9.17 billion in profits. Earnings per share was 7.48.
| Revenue | 54.85B |
| Gross Profit | 39.68B |
| Operating Income | 11.33B |
| Pretax Income | 7.07B |
| Net Income | 9.17B |
| EBITDA | 14.84B |
| EBIT | 11.33B |
| Earnings Per Share (EPS) | 7.48 |
Balance Sheet
The company has 9.01 billion in cash and 23.87 billion in debt, with a net cash position of -14.86 billion.
| Cash & Cash Equivalents | 9.01B |
| Total Debt | 23.87B |
| Net Cash | -14.86B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 84.20B |
| Book Value Per Share | 69.39 |
| Working Capital | 3.06B |
Cash Flow
In the last 12 months, operating cash flow was 12.62 billion and capital expenditures -2.07 billion, giving a free cash flow of 10.55 billion.
| Operating Cash Flow | 12.62B |
| Capital Expenditures | -2.07B |
| Free Cash Flow | 10.55B |
| FCF Per Share | n/a |
Margins
Gross margin is 72.34%, with operating and profit margins of 20.66% and 16.72%.
| Gross Margin | 72.34% |
| Operating Margin | 20.66% |
| Pretax Margin | 12.89% |
| Profit Margin | 16.72% |
| EBITDA Margin | 27.05% |
| EBIT Margin | 20.66% |
| FCF Margin | 19.24% |
Dividends & Yields
Sanofi does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 61.08% |
| Buyback Yield | 2.43% |
| Shareholder Yield | 2.43% |
| Earnings Yield | 8.24% |
| FCF Yield | 9.48% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |